Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial
Article in Frontiers in Pharmacology (May 2023)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers
Article in Scientific Reports (March 2023)
Ketone bodies as treatments for neurological illnesses
Article in Revista Mexicana de Neurociencia (February 2023)